USE OF MYELOPEROXIDASE (MPO) INHIBITORS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT MULTIPLE SYSYEM ATROPHY (MSA) 938

• 收藏
• 分享

专利权人:

ASTRAZENECA AB

发明人:

Hakan Eriksson,Werner Poewe

申请号：

US14075790

公开号：

US20140221400A1

申请日:

2013.11.08

申请国别(地区):

US

年份:

2014

代理人:

摘要：

The present invention relates to the use of MPO inhibitors for the treatment of multiple system atrophy. The present invention also relates to the use of MPO inhibitors for the treatment of Huntington's disease. The present invention also relates to the use of MPO inhibitors for neuroprotection.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/